What is the primary therapeutic use of adenosine?

Adenosine is primarily used for the control of supraventricular tachycardia (SVT). This arrhythmia involves a rapid heart rate originating above the ventricles, and adenosine serves as a highly effective agent in its management. When administered, adenosine temporarily slows down conduction through the atrioventricular (AV) node, resulting in a quick termination of the arrhythmia. Its rapid acting nature (often within seconds) and the ability to restore normal sinus rhythm makes it a preferred choice in acute settings for SVT management.

Its mechanisms do not primarily target hypertension, chronic pain relief, or neutrophil activation directly. Instead, those therapeutic areas require different types of medications that address specific pathophysiological mechanisms distinct from the effects of adenosine. This makes the selection of adenosine for the control of SVT particularly appropriate and effective.